Thorsten Schmidt1, Walter Jonat2, Daniela Wesch3, Hans-Heinrich Oberg3, Sabine Adam-Klages3, Lisa Keller2, Christoph Röcken4, Christoph Mundhenke2. 1. Comprehensive Cancer Center North, University of Kiel, Arnold-Heller Straße 3, Haus 14, 24105, Kiel, Germany. Thorsten.schmidt@uksh.de. 2. OB/GYN, University of Kiel, Arnold-Heller Straße 3, Haus 24, 24105, Kiel, Germany. 3. Institute of Immunology, University of Kiel, Arnold-Heller Straße 3, 24105, Kiel, Germany. 4. Comprehensive Cancer Center North, University of Kiel, Arnold-Heller Straße 3, Haus 14, 24105, Kiel, Germany.
Abstract
PURPOSE:Physical activity can impact the immune system in different ways, e.g. by alteration of the humoral and cellular immune response. Physical activity at medium intensity enhances numbers of cytotoxic T cells, NK cells and macrophages in healthy people. The aim of this study was to compare the effects of endurance and resistance training on the immune system in breast cancer patients during adjuvant chemotherapy. METHODS: In a prospective, controlled and randomized intervention exploratory trial, 12-week supervised endurance or resistance training were compared with usual care twice a week. Endpoints were the absolute numbers of the immune cells such as CD3+ T lymphocytes including CD4+- and CD8+, αβ T cells, γδT cells, CD3-/CD16+/56+ NK cells and CD19+ B cells, before and after 12 weeks of treatment. Cell numbers were analyzed using fluorescence-activated cell sorting. RESULTS: Despite different physical interventions in all groups immune cell count decreased in CD3 T cells including TCR αβ and CD4 T cells, NK cells and CD19 B cells 12 weeks after initiation of chemotherapy and start of the physical intervention program, while the reduction of γδ T cells and CD8 T cells is less prominent in the RT and UC group. CONCLUSION:Chemotherapy led to a decrease in nearly all measured immune cells. In this study, physical intervention with endurance or resistance training did not suppress cellular immunity any further. Larger multicenter trials are needed to evaluate the exact impact of sports intervention on immune cell subpopulations.
RCT Entities:
PURPOSE: Physical activity can impact the immune system in different ways, e.g. by alteration of the humoral and cellular immune response. Physical activity at medium intensity enhances numbers of cytotoxic T cells, NK cells and macrophages in healthy people. The aim of this study was to compare the effects of endurance and resistance training on the immune system in breast cancerpatients during adjuvant chemotherapy. METHODS: In a prospective, controlled and randomized intervention exploratory trial, 12-week supervised endurance or resistance training were compared with usual care twice a week. Endpoints were the absolute numbers of the immune cells such as CD3+ T lymphocytes including CD4+- and CD8+, αβ T cells, γδT cells, CD3-/CD16+/56+ NK cells and CD19+ B cells, before and after 12 weeks of treatment. Cell numbers were analyzed using fluorescence-activated cell sorting. RESULTS: Despite different physical interventions in all groups immune cell count decreased in CD3 T cells including TCR αβ and CD4 T cells, NK cells and CD19 B cells 12 weeks after initiation of chemotherapy and start of the physical intervention program, while the reduction of γδ T cells and CD8 T cells is less prominent in the RT and UC group. CONCLUSION: Chemotherapy led to a decrease in nearly all measured immune cells. In this study, physical intervention with endurance or resistance training did not suppress cellular immunity any further. Larger multicenter trials are needed to evaluate the exact impact of sports intervention on immune cell subpopulations.
Entities:
Keywords:
Breast cancer; Chemotherapy; Immune system; Physical activity
Authors: Amanda D Hagstrom; Paul W M Marshall; Chris Lonsdale; Shona Papalia; Birinder S Cheema; Catherine Toben; Bernhard T Baune; Maria A Fiatarone Singh; Simon Green Journal: Breast Cancer Res Treat Date: 2016-01-28 Impact factor: 4.872
Authors: Elizabeth S Evans; A C Hackney; Robert G McMurray; Scott H Randell; Hyman B Muss; Allison M Deal; Claudio L Battaglini Journal: Integr Cancer Ther Date: 2015-04-14 Impact factor: 3.279
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Clin Otolaryngol Date: 2012-10 Impact factor: 2.597
Authors: Tiffany R Hensley; Austin B Easter; Sarah E Gerdts; Stephen C De Rosa; Antje Heit; M Juliana McElrath; Erica Andersen-Nissen Journal: J Vis Exp Date: 2012-09-16 Impact factor: 1.355
Authors: Adrian S Fairey; Kerry S Courneya; Catherine J Field; Gordon J Bell; Lee W Jones; Blair St Martin; John R Mackey Journal: Brain Behav Immun Date: 2005-09 Impact factor: 7.217
Authors: Thorsten Schmidt; Marion van Mackelenbergh; Daniela Wesch; Christoph Mundhenke Journal: J Cancer Res Ther Date: 2017 Jul-Sep Impact factor: 1.805
Authors: Sandra C Hayes; Sheree Rye; Tracey Disipio; Patsy Yates; John Bashford; Chris Pyke; Christobel Saunders; Diana Battistutta; Elizabeth Eakin Journal: Breast Cancer Res Treat Date: 2012-11-09 Impact factor: 4.872
Authors: Cosima Zemlin; Caroline Stuhlert; Julia Theresa Schleicher; Carolin Wörmann; Laura Altmayer; Marina Lang; Laura-Sophie Scherer; Ida Clara Thul; Carolin Müller; Elisabeth Kaiser; Regine Stutz; Sybelle Goedicke-Fritz; Laura Ketter; Michael Zemlin; Gudrun Wagenpfeil; Georges Steffgen; Erich-Franz Solomayer Journal: Front Oncol Date: 2021-10-19 Impact factor: 6.244
Authors: Daniel Puciato; Michał Rozpara; Władysław Mynarski; Piotr Oleśniewicz; Julita Markiewicz-Patkowska; Małgorzata Dębska Journal: Biomed Res Int Date: 2018-11-01 Impact factor: 3.411
Authors: Leidy Sofía Montaño-Rojas; Ena Monserrat Romero-Pérez; Carlos Medina-Pérez; María Mercedes Reguera-García; José Antonio de Paz Journal: Int J Environ Res Public Health Date: 2020-09-07 Impact factor: 3.390
Authors: Sebastien F M Chastin; Ukachukwu Abaraogu; Jan G Bourgois; Philippa M Dall; Jennifer Darnborough; Elaine Duncan; Jasmien Dumortier; David Jiménez Pavón; Joanna McParland; Nicola J Roberts; Mark Hamer Journal: Sports Med Date: 2021-04-20 Impact factor: 11.136
Authors: Pedro L Valenzuela; Gonzalo Saco-Ledo; Alejandro Lucia; Carmen Fiuza-Luces; Alejandro Santos-Lozano; Javier S Morales; Adrián Castillo-García; Richard J Simpson Journal: Sports Med Open Date: 2022-03-04
Authors: Sergio Rodríguez-Cañamero; Ana Isabel Cobo-Cuenca; Juan Manuel Carmona-Torres; Diana Patricia Pozuelo-Carrascosa; Esmeralda Santacruz-Salas; Joseba Aingerun Rabanales-Sotos; Tatiana Cuesta-Mateos; José Alberto Laredo-Aguilera Journal: Cancer Med Date: 2022-04-11 Impact factor: 4.711
Authors: Hans H Oberg; Christian Kellner; Daniel Gonnermann; Susanne Sebens; Dirk Bauerschlag; Martin Gramatzki; Dieter Kabelitz; Matthias Peipp; Daniela Wesch Journal: Front Immunol Date: 2018-04-19 Impact factor: 7.561